HR 6179
Increasing Access to Biosimilars Act of 2020
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
```json { "summary": "The Increasing Access to Biosimilars Act of 2020 directs the Department of Health and Human Services to establish a three-year demonstration project within Medicare to increase the use of biosimilar biological products. This project would provide participating providers with additional payments based on the cost difference between using a biosimilar and the original reference product. The goal is to evaluate the benefits of these payments and potentially expand the program, while ensuring Medicare beneficiaries’ cost-sharing remains the same.", "keyProvisions": [ "Establishes a 3-year demonstration project within Medicare to evaluate biosimilar use.", "Provides participating providers with additional payments based on cost differences between biosimilars a
Sponsors
Official sponsors from legislative records.
Primary sponsor
Tony Cárdenas
Cosponsors
David B. McKinley
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.